Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Healthcare Triangle (HCTI) EBITDA (2020 - 2025)

Historic EBITDA for Healthcare Triangle (HCTI) over the last 6 years, with Q3 2025 value amounting to -$1.9 million.

  • Healthcare Triangle's EBITDA fell 5212.17% to -$1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.5 million, marking a year-over-year increase of 239.21%. This contributed to the annual value of -$4.7 million for FY2024, which is 3828.95% up from last year.
  • Latest data reveals that Healthcare Triangle reported EBITDA of -$1.9 million as of Q3 2025, which was down 5212.17% from -$1.4 million recorded in Q2 2025.
  • In the past 5 years, Healthcare Triangle's EBITDA ranged from a high of $470000.0 in Q2 2021 and a low of -$10.6 million during Q4 2022
  • Over the past 5 years, Healthcare Triangle's median EBITDA value was -$1.5 million (recorded in 2023), while the average stood at -$2.1 million.
  • In the last 5 years, Healthcare Triangle's EBITDA tumbled by 102467.72% in 2021 and then soared by 8748.47% in 2023.
  • Over the past 5 years, Healthcare Triangle's EBITDA (Quarter) stood at -$3.3 million in 2021, then crashed by 220.09% to -$10.6 million in 2022, then soared by 87.48% to -$1.3 million in 2023, then skyrocketed by 34.53% to -$872000.0 in 2024, then plummeted by 117.89% to -$1.9 million in 2025.
  • Its EBITDA stands at -$1.9 million for Q3 2025, versus -$1.4 million for Q2 2025 and -$1.4 million for Q1 2025.